Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL795808 | 1.00 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL795972 | 1.00 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL12446509 | 0.80 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL771002 | 0.80 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL770949 | 0.80 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL12443927 | 0.80 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL772407 | 0.80 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL803010 | 0.75 | — | — | |
| SCHEMBL802925 | 0.75 | — | — | |
| SCHEMBL802919 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120077932-A1 | COMPOSITIONS BASED ON DIISOCYANATES OBTAINED FROM RENEWABLE RAW MATERIALS | EVONIK DEGUSSA GMBH (DE) | 2012-03-29 | — | — | US | disclosed |
| US-20120073472-A1 | REACTIVE DERIVATIVES ON THE BASIS OF DIANHYDROHEXITOL-BASED ISOCYANATES | EVONIK DEGUSSA GMBH (DE) | 2012-03-29 | — | — | US | disclosed |
| US-20120071577-A1 | USE OF ISOCYANATES BASED ON RENEWABLE RAW MATERIALS | EVONIK DEGUSSA GMBH (DE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120073472-A1 | REACTIVE DERIVATIVES ON THE BASIS OF DIANHYDROHEXITOL-BASED ISOCYANATES | CBR3, IDH1, DERA | ALDH1A1 246/4885 |
| US-20120071577-A1 | USE OF ISOCYANATES BASED ON RENEWABLE RAW MATERIALS | G6PD, DERA, MPI | ALDH1A1 177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.